A detailed history of Eulav Asset Management transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Eulav Asset Management holds 22,100 shares of MEDP stock, worth $6.86 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
22,100
Previous 22,100 -0.0%
Holding current value
$6.86 Million
Previous $9.1 Million 19.02%
% of portfolio
0.18%
Previous 0.25%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $1.41 Million - $1.94 Million
6,200 Added 38.99%
22,100 $6.77 Million
Q4 2021

Feb 11, 2022

BUY
$182.74 - $227.9 $274,110 - $341,850
1,500 Added 10.42%
15,900 $3.46 Million
Q3 2021

Nov 15, 2021

BUY
$170.18 - $198.21 $85,090 - $99,105
500 Added 3.6%
14,400 $2.73 Million
Q4 2019

Feb 13, 2020

BUY
$70.08 - $84.64 $511,584 - $617,872
7,300 Added 110.61%
13,900 $1.17 Million
Q3 2019

Nov 12, 2019

BUY
$62.38 - $85.89 $411,708 - $566,874
6,600 New
6,600 $555,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Eulav Asset Management Portfolio

Follow Eulav Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eulav Asset Management with notifications on news.